title: Visceral leishmaniasis in HIV-infected patients.
authors.forename: M
authors.initials: M
authors.lastname: del Mar Sanz
authors.forename: R
authors.initials: R
authors.lastname: Rubio
authors.forename: A
authors.initials: A
authors.lastname: Casillas
authors.forename: C
authors.initials: C
authors.lastname: Guijarro
authors.forename: J R
authors.initials: JR
authors.lastname: Costa
authors.forename: R
authors.initials: R
authors.lastname: Martinez
authors.forename: J
authors.initials: J
authors.lastname: de Dios Garcia
mesh_terms: D000328:Adult; D000666:Amphotericin B / Q000494:pharmacology; D000981:Antiprotozoal Agents / Q000494:pharmacology; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000473:pathology; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality; D008297:Male; D008536:Meglumine / Q000494:pharmacology; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000494:pharmacology; D010419:Pentamidine / Q000494:pharmacology; D013030:Spain / Q000453:epidemiology; D016896:Treatment Outcome
chemical_list: D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D010419:Pentamidine; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000666:Amphotericin B